Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $180.00 price target on the stock.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com